SMS Lifesciences India manufactures active pharmaceutical ingredients (APIs) and key intermediates, with a strong portfolio in anti-ulcer, anti-infective and CNS segments. Its business model focuses on B2B exports and long-term customer relationships, supporting consistent demand visibility. Management continues to emphasize regulatory compliance and operational efficiency, though the API industry faces challenges like raw material price fluctuations and stringent audits. Capacity utilisation remains stable, while margins largely depend on demand cycles. The company maintains a steady but competitive position in the niche API space. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

#WatchOutFor

1,015 likes·71 comments